Jeremy Burrows, PhD is Vice President, Head of Drug Discovery, at Medicines for Malaria Venture (MMV). Since joining MMV in 2008, he has been responsible for overseeing a growing portfolio of enabling technology, screening, Hit-to-lead and Lead Optimisation projects both with academic and industrial partners. Prior to MMV, he worked at  ZENECA/AstraZeneca as a medicinal chemist working in infection, cardiovascular and inflammation research in the United Kingdom. He also led Lead Generation chemistry delivering new lead series for inflammatory diseases.  In 2005 he was seconded to Sweden in CNS/Pain where he led a section focused on Alzheimer’s disease. In 2013, Dr Burrows he became a Fellow of the Royal Society of Chemistry. He has contributed to the delivery of nine candidate drugs and has published over 80 papers, patent applications and book chapters. He also serves on the advisory committees for several external drug discovery collaborations and regularly reviews articles and grant proposals within the neglected disease area. He earned a master’s degree in Chemistry and Doctor of Philosophy in Synthetic Organic Chemistry at Oxford University (1989–1996).